Archives: Speakers

Ignacio joined Janssen in 2014 as part of the GOLD Program.  He completed 3 international rotations as a Drug Product Demand Planner, Process Engineer, and SAP Master Data Team Lead.  Subsequently Ignacio became the JIT (Just-in-Time) Team Lead while working as a Staff Engineer Tech. Development & Innovation. Driven by curiosity and willingness to help others, Ignacio relocated to Nigeria for 6 months to work for a Maternal and Newborn Health NGO under J&J’s Secondment Program. Shortly after his return, Ignacio joined the CAR-T Systems Group to help deploy end-to-end tools for new emerging modalities within the Biotherapeutics Clinical Supply Chain.

As Vice President of Marketing and Partnerships, Libbi drives enterprise growth through data-driven strategy, integrated marketing leadership, and high-value alliance development. She combines deep expertise in e-clinical innovation and life sciences with a collaborative, cross-functional approach to guide strategic decisions, cultivate impactful partnerships, and translate market insights into measurable outcomes.

Markus is the CEO of LIKE MAGIC (likemagic.tech), bringing strong leadership capabilities and deep expertise in innovation, business transformation, and change management across the financial services (banking and credit cards) and hospitality sectors. He has a proven track record of identifying, designing, and implementing user-centric innovations—both within corporate environments and in collaboration with startups—that deliver measurable impact on business performance and drive sustainable growth.

He continues to demonstrate this skill in his current role as CEO of LIKE MAGIC—a company he successfully built from the ground up and spun out as a subsidiary of SV Group. LIKE MAGIC is now being adopted by an expanding portfolio of hotels and serviced apartment providers across Central and Western Europe, as well as Australia, including Schani Hotels, Stay KooooK, IBIS Styles Nagold, The Zipper Hotel (Hospitality X), McDreams Hotels, and others.

Based in the UK, Chris is responsible for global cell & gene therapy logistics. Since joining Biocair in 2002, Chris has demonstrated Biocair’ s unique client-centric approach by leading teams to deliver in a wide range of challenging situations. He helps meet the complex supply chain needs necessary for commercial distribution of FDA approved therapies

Marcus has been realizing innovative solutions and clinical science in the Pharma space for almost 20 years.

Passionate in driving operational value with technology, the science and the patient is always in focus.

As part of AstraZeneca’s Digital Health transformation, he is aiming to bring greater value to patients faster though technology.

Marcus is gearing up AstraZeneca’s capabilities to take on De-centralized trials, with patient centricity at heart.